BioSpace News Archive

iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that researchers from Miguel Servet University Hospital in Zaragoza, Spain, will present new data from three clinical studies supporting the efficacy of the expanded Xoft® Axxent® Electronic Brachytherapy (eBx®) System®

Global Blood Therapeutics, Inc. announced that members of the senior management team will participate in virtual fireside chats at the following investor conferences:.

Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, today announced that Richard Murray, Ph.D., chief executive officer and president, and Elizabeth Trehu, M.D., chief medical officer, will participate in a fireside chat at the Piper Sandler 32nd Annual Virtual Healthcare Conference.

VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that David Domzalski, Chief Executive Officer, will participate in a fireside chat at the virtual Piper Sandler Healthcare Conference being held December 1-3, 2020.

Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or “The Company”), a leading biosciences and diagnostics company, announced today that Ian B. Walters, MD, has been appointed to the Company’s Board of Directors effective immediately.

BIOREM Inc. (TSXV: BRM) (“Biorem” or “the Company”) today announced its results for the three and nine-month periods ended September 30, 2020. Biorem’s complete third quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).

Applied DNA Sciences, Inc. (NASDAQ:APDN) (“Applied DNA” or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced that the U.S. Food and Drug Administration (FDA) has granted an Emergency Use Authorization (EUA) amendment that expands the installed base of RT-PCR platforms that can process the Company’s Linea™ COVID-19 Assay Kit.

Henry Schein, Inc. (Nasdaq: HSIC) today announced its virtual presence at the Greater New York Dental Meeting (GNYDM), featuring dedicated booths for 3D imaging, 3D printing, and CAD/CAM solutions.

Growing incidences of acute kidney injury have catalyzed the need for improved and quality treatment therapies in the continuous renal replacement therapy landscape.

According to the report, the medical device cleaning market was valued at ~US$ 2.8 Bn in 2018 and is expected to expand at a CAGR of ~5% during the forecast period.